Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.

Aiforia, a Finland-based intelligent pathology technology spinout of University of Helsinki, has picked up €12.6m ($15.4m) in a first series B tranche led by cancer diagnostics technology provider Epredia’s UK division.
The tranche featured Aktia Nordic Micro Cap and unnamed existing investors. The round’s target size is $30.8m.
Founded in 2013 as Fimmic, Aiforia is working on a cloud-based artificial intelligence-equipped software that enables preclinical and clinical image analysis in pathology.
The series B funding has been…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in